{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T11:46:49Z","timestamp":1792324009548,"version":"4.4.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/8\\u20134\/15\/Env\/2020-NCD-II"],"award-info":[{"award-number":["5\/8\\u20134\/15\/Env\/2020-NCD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific & Industrial Research","doi-asserted-by":"publisher","award":["111\\u20132536-319\/2\\u202FK23\/1"],"award-info":[{"award-number":["111\\u20132536-319\/2\\u202FK23\/1"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bioorg.2025.108304","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T10:54:35Z","timestamp":1740221675000},"page":"108304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Quinazoline-2,4(1H,3H)-dione modulates STAT3 and FOXO3a signaling in HepG2 cells"],"prefix":"10.1016","volume":"157","author":[{"given":"Suryaa","family":"Manoharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnasanthiya","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinduja","family":"Gunasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemamalini","family":"Vedagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekambaram","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108304_bb0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12307-016-0183-4","article-title":"Review: the contribution of both nature and nurture to carcinogenesis and progression in solid Tumours","volume":"9","author":"Hyndman","year":"2016","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.bioorg.2025.108304_bb0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.circen.2015.08.015","article-title":"Cell signalling pathways interaction in cellular proliferation: Potential target for therapeutic interventionism","volume":"83","author":"Valdespino-G\u00f3mez","year":"2015","journal-title":"Cirug\u00eda y Cirujanos (English Edition)"},{"key":"10.1016\/j.bioorg.2025.108304_bb0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1535-6108(03)00216-2","article-title":"Cell signaling and cancer","volume":"4","author":"Martin","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioorg.2025.108304_bb0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/1381612826666200115095937","article-title":"Exploring dysregulated signaling pathways in Cancer","volume":"26","author":"Nisar","year":"2020","journal-title":"Curr. Pharm. Des."},{"issue":"2021","key":"10.1016\/j.bioorg.2025.108304_bb0025","first-page":"209","article-title":"GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2025.108304_bb0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41698-018-0048-z","article-title":"Role of nonresolving inflammation in hepatocellular carcinoma development and progression","volume":"2","author":"Yu","year":"2018","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.bioorg.2025.108304_bb0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00042737-200505000-00002","article-title":"Pathogenesis of hepatocellular carcinoma","volume":"17","author":"Moradpour","year":"2005","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioorg.2025.108304_bb0040","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/cancers12030641","article-title":"Inflammatory mechanisms of HCC development","volume":"12","author":"Refolo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2025.108304_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.760971","article-title":"IL-6\/STAT3 is a promising therapeutic target for hepatocellular carcinoma","volume":"11","author":"Xu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2025.108304_bb0050","article-title":"STAT3 and the hyper-IgE syndrome","volume":"2","author":"Mogensen","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.bioorg.2025.108304_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and Cancer","volume":"368","author":"O\u2019Shea","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2025.108304_bb0060","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/cancers11111646","article-title":"STAT3: An emerging therapeutic target for hepatocellular carcinoma","volume":"11","author":"Lee","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2025.108304_bb0065","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.2741\/3886","article-title":"JAK-STAT signaling in hepatic fibrosis","volume":"16","author":"Mair","year":"2011","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bioorg.2025.108304_bb0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cyto.2017.03.018","article-title":"STAT3 in cancer: a double edged sword","volume":"98","author":"Avalle","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.bioorg.2025.108304_bb0075","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.3390\/cancers6031408","article-title":"STAT3 in Cancer\u2014friend or foe?","volume":"6","author":"Zhang","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2025.108304_bb0080","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/onc.2008.20","article-title":"Structure\/function relationships underlying regulation of FOXO transcription factors","volume":"27","author":"Obsil","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2025.108304_bb0085","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4161\/cc.9.6.11035","article-title":"The AMPK-FoxO3A axis as a target for cancer treatment","volume":"9","author":"Chiacchiera","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bioorg.2025.108304_bb0090","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12253-009-9171-z","article-title":"The expression and prognosis of FOXO3a and Skp2 in human hepatocellular carcinoma","volume":"15","author":"Lu","year":"2009","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.bioorg.2025.108304_bb0095","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2013.11.031","article-title":"Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends","volume":"60","author":"Matter","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bioorg.2025.108304_bb0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-018-0856-3","article-title":"Critical role of FOXO3a in carcinogenesis","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2025.108304_bb0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1440-169X.2010.01228.x","article-title":"Active participation of cell death in development and organismal homeostasis","volume":"53","author":"Miura","year":"2011","journal-title":"Develop. Growth Differ."},{"key":"10.1016\/j.bioorg.2025.108304_bb0110","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.molcel.2020.05.014","article-title":"Cell death in the origin and treatment of Cancer","volume":"78","author":"Strasser","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2025.108304_bb0115","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41420-023-01581-0","article-title":"Different types of cell death and their shift in shaping disease","volume":"9","author":"Shen","year":"2023","journal-title":"Cell Death Dis."},{"issue":"2001","key":"10.1016\/j.bioorg.2025.108304_bb0120","first-page":"727","article-title":"Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death","volume":"292","author":"Wei","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.108304_bb0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.biochem.73.011303.073706","article-title":"Cytochrome C-mediated apoptosis","volume":"73","author":"Jiang","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bioorg.2025.108304_bb0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/2159-8290.CD-20-0789","article-title":"Modes of regulated cell death in Cancer","volume":"11","author":"Koren","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2025.108304_bb0135","series-title":"Status of biologic drugs in modern therapeutics-targeted therapies vs. Small Molecule Drugs, in: Biologics, Biosimilars, and Biobetters","first-page":"31","author":"Midlam","year":"2020"},{"key":"10.1016\/j.bioorg.2025.108304_bb0140","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41433-019-0391-5","article-title":"Biologics, biosilimars, and biobetters: Different terms or different drugs?","volume":"33","author":"Sharma","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.bioorg.2025.108304_bb0145","series-title":"Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy","first-page":"117","article-title":"Small molecules and pancreatic Cancer trials and troubles","author":"Govardhanagiri","year":"2019"},{"key":"10.1016\/j.bioorg.2025.108304_bb0150","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.3390\/ijms21155262","article-title":"Mechanisms of action for small molecules revealed by structural biology in drug discovery","volume":"21","author":"Li","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108304_bb0155","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1016\/j.bmcl.2015.07.014","article-title":"Cheminformatic comparison of approved drugs from natural product versus synthetic origins","volume":"25","author":"Stratton","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108304_bb0160","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cbpa.2006.11.038","article-title":"Small molecule approaches in plants","volume":"11","author":"Kaschani","year":"2007","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108304_bb0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3390\/molecules29030585","article-title":"The pharmaceutical industry in 2023: An analysis of FDA drug approvals from the perspective of molecules","volume":"29","author":"de la Torre","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108304_bb0170","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.drudis.2013.01.007","article-title":"The holistic integration of virtual screening in drug discovery","volume":"18","author":"Tanrikulu","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.108304_bb0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2025.108304_bb0180","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1007\/s12010-023-04470-5","article-title":"Potent FOXO3a activators from biologically active compound library for Cancer therapeutics: An in silico approach","volume":"195","author":"Manoharan","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.bioorg.2025.108304_bb0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40484-019-0172-y","article-title":"Progress in molecular docking","volume":"7","author":"Fan","year":"2019","journal-title":"Quantitat. Biolog."},{"key":"10.1016\/j.bioorg.2025.108304_bb0190","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","article-title":"PHASE: A novel approach to pharmacophore modeling and 3D database searching","volume":"67","author":"Dixon","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.108304_bb0195","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/ph15050646","article-title":"Drug design by pharmacophore and virtual screening approach","volume":"15","author":"Giordano","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.108304_bb0200","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108304_bb0205","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s11030-022-10490-w","article-title":"Screening of potent STAT3-SH2 domain inhibitors from JAK\/STAT compound library through molecular dynamics simulation","volume":"27","author":"Manoharan","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2025.108304_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.eti.2021.102068","article-title":"Removal of microbial pathogens and anticancer activity of synthesized nano-thymoquinone from Nigella sativa seeds","volume":"24","author":"Gnanasekaran","year":"2021","journal-title":"Environ. Technol. Innov."},{"key":"10.1016\/j.bioorg.2025.108304_bb0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2025.108304_bb0220","doi-asserted-by":"crossref","first-page":"24838","DOI":"10.1021\/acsomega.0c03527","article-title":"Berbamine (BBM), a natural STAT3 inhibitor, synergistically enhances the antigrowth and Proapoptotic effects of Sorafenib on hepatocellular carcinoma cells","volume":"5","author":"Zhao","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.108304_bb0225","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.tiv.2009.10.020","article-title":"Apoptosis in HepG2 cells exposed to high glucose","volume":"24","author":"Chandrasekaran","year":"2010","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.bioorg.2025.108304_bb0230","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1021\/jf201289e","article-title":"Hispolon induces apoptosis and cell cycle arrest of human hepatocellular carcinoma Hep3B cells by modulating ERK phosphorylation","volume":"59","author":"Huang","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2025.108304_bb0235","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.tiv.2008.03.014","article-title":"Long-term viability and proliferation of alginate-encapsulated 3-D HepG2 aggregates formed in an ultrasound trap","volume":"22","author":"Bazou","year":"2008","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.bioorg.2025.108304_bb0240","first-page":"15863","article-title":"Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line","volume":"8","author":"Huo","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bioorg.2025.108304_bb0245","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2025.108304_bb0250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.gene.2016.03.044","article-title":"Anti-tumor effects of bemiparin in HepG2 and MIA PaCa-2 cells","volume":"585","author":"Alur","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.bioorg.2025.108304_bb0255","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1089\/scd.2012.0030","article-title":"Enhanced hematopoietic differentiation toward erythrocytes from murine embryonic stem cells with HepG2-conditioned medium","volume":"21","author":"Fauzi","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.bioorg.2025.108304_bb0260","series-title":"Identification of ROS Using Oxidized DCFDA and Flow-Cytometry","first-page":"57","author":"Eruslanov","year":"2010"},{"key":"10.1016\/j.bioorg.2025.108304_bb0265","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5897\/AJPP2019.5036","article-title":"Neferine and isoliensinine from Nelumbo nucifera induced reactive oxygen species (ROS)-mediated apoptosis in colorectal cancer HCT-15 cells","volume":"13","author":"Prasath","year":"2019","journal-title":"Afr. J. Pharm. Pharmacol"},{"key":"10.1016\/j.bioorg.2025.108304_bb0270","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0167-4889(98)00088-3","article-title":"Quantitative assay by flow cytometry of the mitochondrial membrane potential in intact cells","volume":"1404","author":"Rottenberg","year":"1998","journal-title":"Biochimica et Biophys. Acta (BBA) - Molecul. Cell Res."},{"key":"10.1016\/j.bioorg.2025.108304_bb0275","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1053\/he.2000.7013","article-title":"Ethanol potentiates tumor necrosis factor-\u03b1 cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition","volume":"31","author":"Pastorino","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.bioorg.2025.108304_bb0280","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/biof.1577","article-title":"Fisetin, a phytopolyphenol, targets apoptotic and necroptotic cell death in HepG2 cells","volume":"46","author":"Sundarraj","year":"2020","journal-title":"BioFactors"},{"key":"10.1016\/j.bioorg.2025.108304_bb0285","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.scr.2011.12.004","article-title":"Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis","volume":"8","author":"Zeng","year":"2012","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.bioorg.2025.108304_bb0290","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1468","article-title":"Next generation 3D pharmacophore modeling","volume":"10","author":"Schaller","year":"2020","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108304_bb0295","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1080\/07391102.2018.1495576","article-title":"Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors","volume":"37","author":"Hu","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.108304_bb0300","doi-asserted-by":"crossref","first-page":"14461","DOI":"10.1038\/s41598-023-41530-6","article-title":"Design, synthesis, computational study and cytotoxic evaluation of some new quinazoline derivatives containing pyrimidine moiety","volume":"13","author":"Zare","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108304_bb0305","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10495-005-6075-6","article-title":"Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments","volume":"10","author":"Rello","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2025.108304_bb0310","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/cancers3011042","article-title":"Cell-centric view of apoptosis and apoptotic cell death-inducing Antitumoral strategies","volume":"3","author":"Apraiz","year":"2011","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2025.108304_bb0315","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4161\/cbt.5.7.2841","article-title":"New symmetrical quinazoline derivatives selectively induce apoptosis in human cancer cells","volume":"5","author":"Cubedo","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bioorg.2025.108304_bb0320","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.108304_bb0325","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1111\/cas.15068","article-title":"Reactive oxygen species in cancer: current findings and future directions","volume":"112","author":"Nakamura","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2025.108304_bb0330","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.7150\/thno.46728","article-title":"Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bioorg.2025.108304_bb0335","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41419-020-2317-3","article-title":"Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS\/MAPK signaling pathway in vitro and in vivo","volume":"11","author":"Fan","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioorg.2025.108304_bb0340","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12885-021-08158-z","article-title":"Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt\/mTOR signaling","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioorg.2025.108304_bb0345","doi-asserted-by":"crossref","first-page":"14329","DOI":"10.1038\/ncomms14329","article-title":"RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108304_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117366","article-title":"Hydroxychloroquine suppresses lung tumorigenesis via inducing FoxO3a nuclear translocation through STAT3 inactivation","volume":"246","author":"Lyu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2025.108304_bb0355","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.3390\/ijms24076038","article-title":"Butein inhibits cell growth by blocking the IL-6\/IL-6R\u03b1 interaction in human ovarian Cancer and by regulation of the IL-6\/STAT3\/FoxO3a pathway","volume":"24","author":"Park","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108304_bb0360","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1038\/sj.onc.1206004","article-title":"Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells","volume":"21","author":"Real","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2025.108304_bb0365","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/cancers6020897","article-title":"STAT3 target genes relevant to human cancers","volume":"6","author":"Carpenter","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2025.108304_bb0370","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/BJ20050465","article-title":"STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells","volume":"392","author":"Bhattacharya","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2025.108304_bb0375","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41388-018-0449-z","article-title":"STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells","volume":"38","author":"Guha","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2025.108304_bb0380","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106700","article-title":"Cell death pathways: Intricate connections and disease implications","volume":"40","author":"Kist","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.bioorg.2025.108304_bb0385","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/cdd.2017.65","article-title":"Initiation and execution mechanisms of necroptosis: An overview","volume":"24","author":"Grootjans","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioorg.2025.108304_bb0390","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12974-018-1235-0","article-title":"Necroptosis: A regulated inflammatory mode of cell death","volume":"15","author":"Dhuriya","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bioorg.2025.108304_bb0395","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.fct.2019.04.012","article-title":"Natural products: An upcoming therapeutic approach to cancer","volume":"128","author":"Dutta","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bioorg.2025.108304_bb0400","first-page":"14","article-title":"Viral infectious disease and natural products with antiviral activity","volume":"1","author":"Kitazato","year":"2007","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.bioorg.2025.108304_bb0405","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/187152711794480429","article-title":"The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders II: Alzheimers Disease","volume":"10","author":"Divino da Rocha","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.bioorg.2025.108304_bb0410","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/med.21733","article-title":"Autophagy and cardiac diseases: therapeutic potential of natural products","volume":"41","author":"Wu","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2025.108304_bb0415","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.sajb.2022.05.028","article-title":"Natural bioactive products as promising therapeutics: A review of natural product-based drug development","volume":"151","author":"Aware","year":"2022","journal-title":"S. Afr. J. Bot."},{"key":"10.1016\/j.bioorg.2025.108304_bb0420","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1039\/b602241n","article-title":"The value of natural products to future pharmaceutical discovery","volume":"24","author":"Baker","year":"2007","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bioorg.2025.108304_bb0425","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0041-0101(00)00154-9","article-title":"Plants as source of drugs","volume":"39","author":"Rates","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.bioorg.2025.108304_bb0430","first-page":"52","article-title":"Drug development from natural resource: A systematic approach, Mini-reviews in medicinal","volume":"15","author":"Sharma","year":"2015","journal-title":"Chemistry"},{"key":"10.1016\/j.bioorg.2025.108304_bb0435","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cbpa.2005.04.001","article-title":"Complex molecules: Do they add value?","volume":"9","author":"Selzer","year":"2005","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108304_bb0440","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/19768354.2022.2157480","article-title":"Drug discovery inspired by bioactive small molecules from nature","volume":"26","author":"Kim","year":"2022","journal-title":"Anim Cells Syst (Seoul)"},{"key":"10.1016\/j.bioorg.2025.108304_bb0445","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: Advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.108304_bb0450","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1021\/jacsau.2c00415","article-title":"The time and place for nature in drug discovery","volume":"2","author":"Young","year":"2022","journal-title":"JACS Au"},{"key":"10.1016\/j.bioorg.2025.108304_bb0455","doi-asserted-by":"crossref","first-page":"15705","DOI":"10.1002\/anie.202016575","article-title":"Pseudo natural products\u2014chemical evolution of natural product structure","volume":"60","author":"Karageorgis","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108304_bb0460","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbpa.2019.10.005","article-title":"Pseudo-natural products and natural product-inspired methods in chemical biology and drug discovery","volume":"56","author":"Grigalunas","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108304_bb0465","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201800152","article-title":"Four natural compounds separated from folium Isatidis: crystal structures and antibacterial activity","volume":"15","author":"Liao","year":"2018","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2025.108304_bb0470","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/90700609","article-title":"Syntheses of Quinazoline-2,4-dione alkaloids and analogues from Mexican Zanthoxylum species \u2020","volume":"9","author":"Rivero","year":"2004","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108304_bb0475","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/np0305425","article-title":"Quinazolin-4-one derivatives from Streptomyces isolates","volume":"67","author":"Maskey","year":"2004","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2025.108304_bb0480","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bmc.2004.10.053","article-title":"Design, synthesis, and evaluation of potent and selective benzoyleneurea-based inhibitors of protein geranylgeranyltransferase-I","volume":"13","author":"Carrico","year":"2005","journal-title":"Bioorg. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825001841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:58:41Z","timestamp":1777463921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825001841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":96,"alternative-id":["S0045206825001841"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108304","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quinazoline-2,4(1H,3H)-dione modulates STAT3 and FOXO3a signaling in HepG2 cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108304"}}